OMNImet™·GUT expands access to critical metabolomic analysis with development of in-home fecal collection device – the first device for in-home collection and ambient-temperature storage and shipping of fecal samples for metabolomics, to the research market.
“One of the unique characteristics of metabolomics is its ability to reveal functionality. This is of great benefit as it can help to fill the gaps of other ’omics where insights may be lacking. Scientists can use metabolomics to provide a bridge with other ’omic approaches to more completely understand disease manifestation and state of the phenotype in the present time.” - Annie Evans, Director of R&D at Metabolon.
Metabolomic insights will support Army’s research into Warfighter health-readiness and optimal performance. Metabolon, Inc., the global leader in metabolomics, has been selected by the U.S. Army Research Institute of Environmental Medicine (USARIEM), to analyze the metabolic profiles of military personnel in a research program being conducted by the Military Nutrition Division.
Join over 800 scientific leaders at the flagship Cell Series UK, connecting regenerative medicine and bioprocessing experts to transform cell research and therapies.
Visit us at booth 610
Connect with 2000+ global scientists, engineers and executives working across the entire spectrum of biopharmaceutical development and production.
Join Metabolon’s Annie Evans, Ph.D., Director of R&D, and Greg Michelotti, Ph.D., Scientific Director of Biology, for our webinar: Proteomics and Metabolomics: A Technology Overview. During this event, we will compare and contrast how best to leverage these technologies to advance your research.
IGES is the International Genetic Epidemiology Society, a scientific society concerned with “the study of genetic components in complex biological phenomena” according to James V. Neel, the founding President of the Society. The successful mapping of the human genome will greatly facilitate the study of health and disease in a manner that integrates both host and environmental factors.
Join Metabolon’s Patricia Sheridan, Ph.D., Senior Study Director, Discovery & Translational Sciences, for a conversation with Dr. Heath on May 27th at 11:00 am EDT/13:00 CEST. They will be discussing some of the current work that ISB is doing to explore COVID-19 infections and how metabolomics can be used to understand the pathophysiology of the infection.
Enlighten your research,
accelerate your discovery.
Metabolon, Inc. and DNA Genotek Collaborate on First Ambient-Temperature Microbiome Sampling Solution for Metabolomics
Clinical OMICs: ’Omics in Translation
Metabolon Wins Five Year Contract with U.S. Army Research Institute of Environmental Medicine